November 06, 2021
Results of the 5-year follow-up from SURTAVI, which were presented at TCT 2021, provide insight into the associations of TAVR with mortality and stroke compared to SAVR in patients with severe aortic stenosis considered to be at intermediate risk.
November 04, 2021
Data from the FAME 3 trial cast doubt on the role of FFR-guided PCI versus CABG among patients with 3-vessel coronary artery disease.
October 20, 2020
Practical Cardiology advisory board member Tsuyoshi Kaneko, MD, reflects on 3 studies examining topics related to TAVR from late-breaking sessions at TCT Connect 2020.
October 19, 2020
Results of the SCOPE II trial from TCT Connect offer insight into the head-to-head comparison of ACURATE neo valve versus the CoreValve Evolut R System.
October 18, 2020
Results of REDUCE-IT PCI detail a 34% reduction in 5-point MACE and a 39% reduction in total events among patients receiving icosapent ethyl (Vascepa) in the original trial with a history of PCI.
October 16, 2020
Results from 3-year follow-up of the ULTIMATE study indicate IVUS-guided PCI was associated with lower rates of TVF and stent thrombosis.
October 15, 2020
A trial presented at TCT 2020 suggests crushed prasugrel provided no reperfusion benefit when compared against integral tablet in STEMI patients.